Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins

Human papillomavirus (HPV) is strongly implicated as a causative agent in the etiology of cervical cancer. Of its gene products, E6 binds to and inactivates p53 tumor suppressor protein by ubiquitin/proteasome‐dependent degradation. Recently, p73, a novel family of p53, has been identified and demon...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cancer Vol. 91; no. 6; pp. 822 - 827
Main Authors Park, Jong‐Sup, Kim, Eun‐Joo, Lee, Jung‐Young, Sin, Hong‐Sig, Namkoong, Sung‐Eun, Um, Soo‐Jong
Format Journal Article
LanguageEnglish
Published New York John Wiley & Sons, Inc 15.03.2001
Wiley-Liss
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Human papillomavirus (HPV) is strongly implicated as a causative agent in the etiology of cervical cancer. Of its gene products, E6 binds to and inactivates p53 tumor suppressor protein by ubiquitin/proteasome‐dependent degradation. Recently, p73, a novel family of p53, has been identified and demonstrated, like p53, to activate p21WAF1. Here we show that p73 is also inactivated by HPV‐E6, but ubiquitin‐mediated proteolysis is not responsive. Yeast two‐hybrid and GST pull‐down assays indicate a physical interaction between p73 and either HPV‐16 or HPV‐11 E6 proteins in vivo and in vitro, respectively. The transactivation domain (amino acid residues 1 to 49) is found to be absolutely required for the interaction. Transient co‐expression of E6 significantly inhibits the p73‐mdiated activation of p21WAF1 promoter in a p53‐defective C33A cell line. Using Gal4‐p73 fusion protein, we demonstrate that E6 inhibition of p73 transactivation function is independent of sequence‐specific DNA binding, which is confirmed by a direct electrophoretic mobility shift assay. Moreover, E6 inhibits p73 function by interfering with the activity of the amino‐terminal activation domain. Co‐transfection of E6 mutants reveals that the same portion of E6 appears to be responsible for the inactivation of p53 and p73 function. However, the inactivation mechanism of p73 is clearly different from that of p53, because p73, unlike p53, is inactivated by both high‐ and low‐risk E6s and is not susceptible to E6‐dependent proteolysis. These overall results, consequently, suggest that in addition to the inactivation of p53, the functional interference of p73 by HPV‐E6 may, at least in part, contribute to E6‐mediated transformation and hyperproliferation of cervical cells. © 2001 Wiley‐Liss, Inc.
AbstractList Human papillomavirus (HPV) is strongly implicated as a causative agent in the etiology of cervical cancer. Of its gene products, E6 binds to and inactivates p53 tumor suppressor protein by ubiquitin/proteasome-dependent degradation. Recently, p73, a novel family of p53, has been identified and demonstrated, like p53, to activate p21 super(WAF1). Here we show that p73 is also inactivated by HPV-E6, but ubiquitin-mediated proteolysis is not responsive. Yeast two-hybrid and GST pull-down assays indicate a physical interaction between p73 and either HPV-16 or HPV-11 E6 proteins in vivo and in vitro, respectively. The transactivation domain (amino acid residues 1 to 49) is found to be absolutely required for the interaction. Transient co-expression of E6 significantly inhibits the p73-mediated activation of p21 super(WAF1) promoter in a p53-defective C33A cell line. Using Gal4-p73 fusion protein, we demonstrate that E6 inhibition of p73 transactivation function is independent of sequence-specific DNA binding, which is confirmed by a direct electrophoretic mobility shift assay. Moreover, E6 inhibits p73 function by interfering with the activity of the amino-terminal activation domain. Co-transfection of E6 mutants reveals that the same portion of E6 appears to be responsible for the inactivation of p53 and p73 function. However, the inactivation mechanism of p73 is clearly different from that of p53, because p73, unlike p53, is inactivated by both high- and low-risk E6s and is not susceptible to E6-dependent proteolysis. These overall results, consequently, suggest that in addition to the inactivation of p53, the functional interference of p73 by HPV-E6 may, at least in part, contribute to E6-mediated transformation and hyperproliferation of cervical cells.
Human papillomavirus (HPV) is strongly implicated as a causative agent in the etiology of cervical cancer. Of its gene products, E6 binds to and inactivates p53 tumor suppressor protein by ubiquitin/proteasome‐dependent degradation. Recently, p73, a novel family of p53, has been identified and demonstrated, like p53, to activate p21WAF1. Here we show that p73 is also inactivated by HPV‐E6, but ubiquitin‐mediated proteolysis is not responsive. Yeast two‐hybrid and GST pull‐down assays indicate a physical interaction between p73 and either HPV‐16 or HPV‐11 E6 proteins in vivo and in vitro, respectively. The transactivation domain (amino acid residues 1 to 49) is found to be absolutely required for the interaction. Transient co‐expression of E6 significantly inhibits the p73‐mdiated activation of p21WAF1 promoter in a p53‐defective C33A cell line. Using Gal4‐p73 fusion protein, we demonstrate that E6 inhibition of p73 transactivation function is independent of sequence‐specific DNA binding, which is confirmed by a direct electrophoretic mobility shift assay. Moreover, E6 inhibits p73 function by interfering with the activity of the amino‐terminal activation domain. Co‐transfection of E6 mutants reveals that the same portion of E6 appears to be responsible for the inactivation of p53 and p73 function. However, the inactivation mechanism of p73 is clearly different from that of p53, because p73, unlike p53, is inactivated by both high‐ and low‐risk E6s and is not susceptible to E6‐dependent proteolysis. These overall results, consequently, suggest that in addition to the inactivation of p53, the functional interference of p73 by HPV‐E6 may, at least in part, contribute to E6‐mediated transformation and hyperproliferation of cervical cells. © 2001 Wiley‐Liss, Inc.
Human papillomavirus (HPV) is strongly implicated as a causative agent in the etiology of cervical cancer. Of its gene products, E6 binds to and inactivates p53 tumor suppressor protein by ubiquitin/proteasome-dependent degradation. Recently, p73, a novel family of p53, has been identified and demonstrated, like p53, to activate p21(WAF1). Here we show that p73 is also inactivated by HPV-E6, but ubiquitin-mediated proteolysis is not responsive. Yeast two-hybrid and GST pull-down assays indicate a physical interaction between p73 and either HPV-16 or HPV-11 E6 proteins in vivo and in vitro, respectively. The transactivation domain (amino acid residues 1 to 49) is found to be absolutely required for the interaction. Transient co-expression of E6 significantly inhibits the p73-mdiated activation of p21(WAF1) promoter in a p53-defective C33A cell line. Using Gal4-p73 fusion protein, we demonstrate that E6 inhibition of p73 transactivation function is independent of sequence-specific DNA binding, which is confirmed by a direct electrophoretic mobility shift assay. Moreover, E6 inhibits p73 function by interfering with the activity of the amino-terminal activation domain. Co-transfection of E6 mutants reveals that the same portion of E6 appears to be responsible for the inactivation of p53 and p73 function. However, the inactivation mechanism of p73 is clearly different from that of p53, because p73, unlike p53, is inactivated by both high- and low-risk E6s and is not susceptible to E6-dependent proteolysis. These overall results, consequently, suggest that in addition to the inactivation of p53, the functional interference of p73 by HPV-E6 may, at least in part, contribute to E6-mediated transformation and hyperproliferation of cervical cells.
Author Kim, Eun‐Joo
Lee, Jung‐Young
Park, Jong‐Sup
Sin, Hong‐Sig
Um, Soo‐Jong
Namkoong, Sung‐Eun
Author_xml – sequence: 1
  givenname: Jong‐Sup
  surname: Park
  fullname: Park, Jong‐Sup
– sequence: 2
  givenname: Eun‐Joo
  surname: Kim
  fullname: Kim, Eun‐Joo
– sequence: 3
  givenname: Jung‐Young
  surname: Lee
  fullname: Lee, Jung‐Young
– sequence: 4
  givenname: Hong‐Sig
  surname: Sin
  fullname: Sin, Hong‐Sig
– sequence: 5
  givenname: Sung‐Eun
  surname: Namkoong
  fullname: Namkoong, Sung‐Eun
– sequence: 6
  givenname: Soo‐Jong
  surname: Um
  fullname: Um, Soo‐Jong
  email: umsj@sejong.ac.kr
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=973438$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/11275986$$D View this record in MEDLINE/PubMed
BookMark eNqVkdtu1DAQhi1URLeFV0CWkBBIzTJjJ3ayRUhVaGFRpb3gcGt5vQ4NSuw03hTt2-OQtNwgIXwxHo--OXj-E3LkvLOEnCMsEYC9QShkAgyzVwziYa-LeFajebtaXazfJ-tPJSKHd3wJy3JzzhJ4RBYPWUdkEZMgkcjFMTkJ4QcAYgbpE3KMyGRW5GJB3NXgzL72Tje0djq6d3p8Ul_RTvIzqumNb33jv_-OZJzuh9b3NAxd19sQotv1fm9rd0a3B3oztNrRTnd10_hW39X9EOiluGfCU_K40k2wz-b7lHy9uvxSfkyuNx_W5cV1YlLEOLMAgTxnLBUI0akQstQAguZaFrk0eZEWO6GZqSrJpSkk3-ZFtatEhUZb5Kfk5VQ3Nr4dbNirtg7GNo121g9BSQkgJMp_gihzngsUEfw8gab3IfS2Ul1ft7o_KAQ16qXGzatx82rSS41STUapqJea9VJcgSo3iimIVZ_P7Ydta3d_as4CReDFDOhgdFP12pk6PHDx4ynPI_Vton7WjT38z2R_n-s-xH8Bz827UQ
CODEN IJCNAW
Cites_doi 10.1128/MCB.18.11.6316
10.1016/0092-8674(92)90644-R
10.1016/S0092-8674(00)80540-1
10.1038/38298
10.1101/gad.12.13.2061
10.1128/JVI.66.7.4201-4208.1992
10.1128/MCB.13.8.4918
10.1038/sj.bjc.6690027
10.1002/(SICI)1097-0215(19990812)82:4<583::AID-IJC18>3.0.CO;2-G
10.1074/jbc.275.10.6764
10.1101/gad.8.2.190
10.1128/MCB.16.5.2101
10.1074/jbc.273.1.1
10.1073/pnas.91.6.2230
10.2144/96206bm03
10.1006/viro.1995.1511
10.1128/JVI.68.7.4656-4661.1994
10.1006/viro.1996.8315
10.1002/(SICI)1097-0045(19990501)39:2<94::AID-PROS3>3.0.CO;2-W
10.1128/JVI.72.2.1165-1170.1998
ContentType Journal Article
Copyright Copyright © 2001 Wiley‐Liss, Inc.
2001 INIST-CNRS
Copyright 2001 Wiley-Liss, Inc.
Copyright_xml – notice: Copyright © 2001 Wiley‐Liss, Inc.
– notice: 2001 INIST-CNRS
– notice: Copyright 2001 Wiley-Liss, Inc.
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TO
7U9
H94
7X8
DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList Oncogenes and Growth Factors Abstracts

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0215
EndPage 827
ExternalDocumentID 10_1002_1097_0215_200002_9999_9999___AID_IJC1130_3_0_CO_2_0
11275986
973438
IJC1130
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Korean Ministry of Health and Welfare, KOSEF, Ministry of Science and Technology (Life Phenomenon & Function Research)
  funderid: HMP‐00‐B‐20200‐0004, 1999‐1‐209‐007‐5, 200‐BTF‐14
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EX3
F00
F01
F04
F5P
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
SUPJJ
UB1
UDS
V2E
V8K
V9Y
VH1
W2D
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
X7M
XG1
XPP
XV2
ZGI
ZZTAW
~IA
~WT
8WZ
A6W
AAJUZ
AAPBV
AAUGY
AAVGM
ABCVL
ABEFU
ABEML
ABHUG
ABWRO
ACBWZ
ACSCC
ACSMX
ACXME
ADAWD
ADDAD
AFVGU
AGJLS
AHEFC
ASPBG
AVWKF
AZFZN
BDRZF
C45
EMOBN
FEDTE
GLUZI
HF~
IQODW
M6P
OVD
PALCI
RYL
SAMSI
TEORI
Y6R
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TO
7U9
H94
7X8
ID FETCH-LOGICAL-c4110-7606138224610138f1054c010a3a7987c8949d6a2cff737c973b89fdf6f1cae13
IEDL.DBID DR2
ISSN 0020-7136
IngestDate Fri Aug 16 10:47:58 EDT 2024
Fri Aug 16 23:53:16 EDT 2024
Fri Aug 23 03:59:38 EDT 2024
Sat Sep 28 08:36:30 EDT 2024
Sun Oct 22 16:08:26 EDT 2023
Sat Aug 24 01:03:33 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Human
Homology
Papovaviridae
Uterine cervix
Malignant tumor
Inactivation
Carcinogenesis
Female genital diseases
Infection
Papillomavirus
Virus
Human papillomavirus
TP53 Gene
Viral disease
Genetics
Uterine cervix diseases
Tumor suppressor gene
Language English
License CC BY 4.0
Copyright 2001 Wiley-Liss, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4110-7606138224610138f1054c010a3a7987c8949d6a2cff737c973b89fdf6f1cae13
Notes J.‐S. Park and E.‐J. Kim contributed equally to this work.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1130%3E3.0.CO%3B2-0
PMID 11275986
PQID 17838616
PQPubID 23462
PageCount 6
ParticipantIDs proquest_miscellaneous_77006717
proquest_miscellaneous_17838616
crossref_primary_10_1002_1097_0215_200002_9999_9999___AID_IJC1130_3_0_CO_2_0
pubmed_primary_11275986
pascalfrancis_primary_973438
wiley_primary_10_1002_1097_0215_200002_9999_9999_AID_IJC1130_3_0_CO_2_0_IJC1130
PublicationCentury 2000
PublicationDate 15 March 2001
PublicationDateYYYYMMDD 2001-03-15
PublicationDate_xml – month: 03
  year: 2001
  text: 15 March 2001
  day: 15
PublicationDecade 2000
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: New York, NY
– name: United States
PublicationTitle International journal of cancer
PublicationTitleAlternate Int J Cancer
PublicationYear 2001
Publisher John Wiley & Sons, Inc
Wiley-Liss
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley-Liss
References 1993; 8
1996; 380
1993; 1155
1994; 68
1995; 212
2000; 275
1999; 82
1996; 16
1998; 273
1994; 9
1997; 389
1997; 90
1994; 8
1993; 13
1998; 18
1997; 227
1999; 39
1996; 1288
1999; 79
1992; 69
1998; 72
1994; 91
1992; 66
1998; 12
1996; 20
1998; 58
Massimi (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB25) 1997; 227
Yokomizo (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB15) 1999; 39
Schittek (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB16) 1999; 82
Jost (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB11) 1997; 389
Kiyono (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB6) 1994; 68
Yew (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB22) 1994; 8
Jiang (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB20) 1993; 8
Schneider (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB19) 1996; 20
Steegenga (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB26) 1996; 16
Mansur (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB2) 1993; 1155
Park (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB18) 2000; 275
Kaghad (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB12) 1997; 90
Nomoto (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB13) 1998; 58
Keen (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB8) 1994; 9
Zur Hausen (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB1) 1996; 1288
Agarwal (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB4) 1998; 273
Ronco (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB9) 1998; 12
Huibregtse (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB3) 1993; 13
Wang (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB21) 1994; 91
Marin (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB17) 1998; 18
Nakagawa (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB7) 1995; 212
Mihara (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB14) 1999; 79
Pise-Masison (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB23) 1998; 72
Kligelhutz (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB10) 1996; 380
Sedman (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB5) 1992; 66
Momand (10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB24) 1992; 69
References_xml – volume: 39
  start-page: 94
  year: 1999
  end-page: 100
  article-title: Mutation and expression analysis of the p73 gene in prostate cancer
  publication-title: Prostate
– volume: 8
  start-page: 2805
  year: 1993
  end-page: 12
  article-title: SV40 T antigen abrogates p53‐mediated transcriptional activity
  publication-title: Oncogene
– volume: 9
  start-page: 1493
  year: 1994
  end-page: 9
  article-title: Interaction of the E6 protein of human papillomavirus with cellular proteins
  publication-title: Oncogene
– volume: 1155
  start-page: 323
  year: 1993
  end-page: 5
  article-title: Cellular transformation by papillomavirus oncoproteins
  publication-title: Biochem Biophys Acta
– volume: 12
  start-page: 2061
  year: 1998
  end-page: 2
  article-title: Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor‐3 and inhibits its transcriptional activity
  publication-title: Genes Dev
– volume: 90
  start-page: 809
  year: 1997
  end-page: 9
  article-title: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
  publication-title: Cell
– volume: 82
  start-page: 583
  year: 1999
  article-title: Lack of p73 mutations and late occurrence of p73 allelic deletions in melanoma tissues and cell lines
  publication-title: Int J Cancer
– volume: 79
  start-page: 164
  year: 1999
  article-title: Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma
  publication-title: Br J Cancer
– volume: 91
  start-page: 2230
  year: 1994
  end-page: 4
  article-title: Hepatitis B virus X protein inhibits p53 sequence‐specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
  publication-title: Proc Natl Acad Sci USA
– volume: 20
  start-page: 960
  year: 1996
  end-page: 2
  article-title: An in vitro assay of β‐galactosidase from yeast
  publication-title: Biotechniques
– volume: 69
  start-page: 1237
  year: 1992
  end-page: 5
  article-title: The mdm‐2 oncogene product forms a complex with the p53 protein and inhibits p53‐mediated transactivation
  publication-title: Cell
– volume: 13
  start-page: 4918
  year: 1993
  end-page: 7
  article-title: Localization of the E6‐AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins
  publication-title: Mol Cell Biol
– volume: 8
  start-page: 190
  year: 1994
  end-page: 202
  article-title: Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53
  publication-title: Genes Dev
– volume: 212
  start-page: 535
  year: 1995
  end-page: 2
  article-title: Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro
  publication-title: Virology
– volume: 1288
  start-page: F55
  year: 1996
  end-page: F78
  article-title: Papillomavirus infections—a major cause of human cancers
  publication-title: Biochem Biophys Acta
– volume: 389
  start-page: 191
  year: 1997
  end-page: 4
  article-title: p73 is a human p53‐related protein that can induce apoptosis
  publication-title: Nature
– volume: 58
  start-page: 1380
  year: 1998
  article-title: Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers
  publication-title: Cancer Res
– volume: 18
  start-page: 6316
  year: 1998
  end-page: 4
  article-title: Viral oncoproteins discriminate between p53 and the p53 homolog p73
  publication-title: Mol Cell Biol
– volume: 66
  start-page: 4201
  year: 1992
  end-page: 8
  article-title: Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6‐associated trans‐activation or transforming activity
  publication-title: J Virol
– volume: 16
  start-page: 2101
  year: 1996
  end-page: 9
  article-title: Adenovirus E1A proteins inhibit activation of transcription by p53
  publication-title: Mol Cell Biol
– volume: 68
  start-page: 4656
  year: 1994
  end-page: 61
  article-title: Inhibition of p53‐mediated transactivation by E6 of type 1, but not type 5, 8, or 47, human papillomavirus of cutaneous origin
  publication-title: J Virol
– volume: 227
  start-page: 255
  year: 1997
  end-page: 9
  article-title: Repression of the p53 transcriptional activity by the HPV E7 proteins
  publication-title: Virology
– volume: 273
  start-page: 1
  year: 1998
  end-page: 4
  article-title: The p53 network
  publication-title: J Biol Chem
– volume: 275
  start-page: 6764
  year: 2000
  end-page: 9
  article-title: Inactivation of interferon regulatory factor‐1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7‐mediated immune evasion mechanism in cervical carcinogenesis
  publication-title: J Biol Chem
– volume: 380
  start-page: 78
  year: 1996
  end-page: 81
  article-title: Telomerase activation by the E6 gene product of human papillomavirus type 16
  publication-title: Nature
– volume: 72
  start-page: 1165
  year: 1998
  end-page: 70
  article-title: Inhibition of p53 transactivation function by the human T‐cell lymphotropic virus type 1 Tax protein
  publication-title: J Virol
– volume: 18
  start-page: 6316
  year: 1998
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB17
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.18.11.6316
  contributor:
    fullname: Marin
– volume: 69
  start-page: 1237
  year: 1992
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB24
  publication-title: Cell
  doi: 10.1016/0092-8674(92)90644-R
  contributor:
    fullname: Momand
– volume: 90
  start-page: 809
  year: 1997
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB12
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80540-1
  contributor:
    fullname: Kaghad
– volume: 389
  start-page: 191
  year: 1997
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB11
  publication-title: Nature
  doi: 10.1038/38298
  contributor:
    fullname: Jost
– volume: 12
  start-page: 2061
  year: 1998
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB9
  publication-title: Genes Dev
  doi: 10.1101/gad.12.13.2061
  contributor:
    fullname: Ronco
– volume: 58
  start-page: 1380
  year: 1998
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB13
  publication-title: Cancer Res
  contributor:
    fullname: Nomoto
– volume: 66
  start-page: 4201
  year: 1992
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB5
  publication-title: J Virol
  doi: 10.1128/JVI.66.7.4201-4208.1992
  contributor:
    fullname: Sedman
– volume: 13
  start-page: 4918
  year: 1993
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB3
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.13.8.4918
  contributor:
    fullname: Huibregtse
– volume: 79
  start-page: 164
  year: 1999
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB14
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6690027
  contributor:
    fullname: Mihara
– volume: 82
  start-page: 583
  year: 1999
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB16
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(19990812)82:4<583::AID-IJC18>3.0.CO;2-G
  contributor:
    fullname: Schittek
– volume: 275
  start-page: 6764
  year: 2000
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB18
  publication-title: J Biol Chem
  doi: 10.1074/jbc.275.10.6764
  contributor:
    fullname: Park
– volume: 8
  start-page: 190
  year: 1994
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB22
  publication-title: Genes Dev
  doi: 10.1101/gad.8.2.190
  contributor:
    fullname: Yew
– volume: 8
  start-page: 2805
  year: 1993
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB20
  publication-title: Oncogene
  contributor:
    fullname: Jiang
– volume: 1288
  start-page: f55
  year: 1996
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB1
  publication-title: Biochem Biophys Acta
  contributor:
    fullname: Zur Hausen
– volume: 16
  start-page: 2101
  year: 1996
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB26
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.16.5.2101
  contributor:
    fullname: Steegenga
– volume: 273
  start-page: 1
  year: 1998
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB4
  publication-title: J Biol Chem
  doi: 10.1074/jbc.273.1.1
  contributor:
    fullname: Agarwal
– volume: 91
  start-page: 2230
  year: 1994
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB21
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.91.6.2230
  contributor:
    fullname: Wang
– volume: 380
  start-page: 78
  year: 1996
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB10
  publication-title: Nature
  contributor:
    fullname: Kligelhutz
– volume: 20
  start-page: 960
  year: 1996
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB19
  publication-title: Biotechniques
  doi: 10.2144/96206bm03
  contributor:
    fullname: Schneider
– volume: 212
  start-page: 535
  year: 1995
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB7
  publication-title: Virology
  doi: 10.1006/viro.1995.1511
  contributor:
    fullname: Nakagawa
– volume: 68
  start-page: 4656
  year: 1994
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB6
  publication-title: J Virol
  doi: 10.1128/JVI.68.7.4656-4661.1994
  contributor:
    fullname: Kiyono
– volume: 227
  start-page: 255
  year: 1997
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB25
  publication-title: Virology
  doi: 10.1006/viro.1996.8315
  contributor:
    fullname: Massimi
– volume: 1155
  start-page: 323
  year: 1993
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB2
  publication-title: Biochem Biophys Acta
  contributor:
    fullname: Mansur
– volume: 39
  start-page: 94
  year: 1999
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB15
  publication-title: Prostate
  doi: 10.1002/(SICI)1097-0045(19990501)39:2<94::AID-PROS3>3.0.CO;2-W
  contributor:
    fullname: Yokomizo
– volume: 72
  start-page: 1165
  year: 1998
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB23
  publication-title: J Virol
  doi: 10.1128/JVI.72.2.1165-1170.1998
  contributor:
    fullname: Pise-Masison
– volume: 9
  start-page: 1493
  year: 1994
  ident: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0-BIB8
  publication-title: Oncogene
  contributor:
    fullname: Keen
SSID ssj0011504
Score 1.9514515
Snippet Human papillomavirus (HPV) is strongly implicated as a causative agent in the etiology of cervical cancer. Of its gene products, E6 binds to and inactivates...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 822
SubjectTerms AE6 protein
Ap73 protein
Apoptosis
Biological and medical sciences
Blotting, Western
cervical cancer
Cyclin-Dependent Kinase Inhibitor p21
Cyclins - metabolism
DNA - metabolism
DNA-Binding Proteins - genetics
DNA-Binding Proteins - metabolism
E6 protein
Electrophoresis, Agar Gel
Enzyme-Linked Immunosorbent Assay
Female genital diseases
Genes, Tumor Suppressor - physiology
Glutathione Transferase - chemistry
Gynecology. Andrology. Obstetrics
HPV
Human papillomavirus 11
human papillomavirus 16
Humans
Medical sciences
Mutation
Nuclear Proteins - genetics
Nuclear Proteins - metabolism
Oncogene Proteins, Viral - genetics
Oncogene Proteins, Viral - metabolism
p53
p73
p73 protein
Papillomaviridae - physiology
Protein Binding
Recombinant Fusion Proteins - metabolism
Transfection
Tumor Cells, Cultured
Tumor Protein p73
Tumor Suppressor Protein p53 - genetics
Tumor Suppressor Protein p53 - metabolism
Tumor Suppressor Proteins
Tumor Virus Infections - virology
Tumors
Two-Hybrid System Techniques
Waf1 gene
Title Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1130%3E3.0.CO%3B2-0
https://www.ncbi.nlm.nih.gov/pubmed/11275986
https://search.proquest.com/docview/17838616
https://search.proquest.com/docview/77006717
Volume 91
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1ta9RAEF5KPxRBfNderbofLCg01-Q2ty9XEWq8oy3WA7HQb8sm2eDRXhIuF0F_iL_XmWxy9aR-EMQQkrAkO8lkdveZ3Z1nCXkpoBWyvso8pYTywjAxnhEMw7h4ahh4AEOF0chnH_nxeXh6MbzYIHUXC-P4IVYdblgymvoaC7iJq4Nr0lAcOvX8hhtBYrwJJirc4Ne6UwRXsB-dvPdOTqMAaus9NmZ9vx9N99i7gYeePlLwIZT6tCKdQojUcjf7HrhwfIsctlIPVjJfOYmvUdAID29Go1_kvHVSDkHGWnt3uzQVqD5za2bcBGrXMXLTyE3ukh-detzclst-vYz7yfffmCP_u_7ukTstbKZHzs7vkw2bPyBbZ-3EgIckn0D77Lo16SzHYA3X1UyLjJaC7VNDvxRzrOiblCGjy3peLGhVl81MYLhsGCtm-T6Nv9Fm5UJamnJ2dVXMzdfZoq7omHf3VI_I-WT8OTr22qUkvCQEgOMJjrhFNux5ODabAawME_BFDTNCSZFIFaqUm0GSZYKJRAkWS5WlGc-CxNiAPSabeZHbbUJT5Gi1iEs5eHtpqDJreQhAMk1sLGXYIx-6H65LxxiiHTf0oB3uB51rp3GNinYHrUHPutWzZtrX0VQPtN8ju2tGs8oTXjFkskdedDakoWLA0R6T26KudCAkkzzgf75DCMQqgeiRJ874rt8Xaf-VhGenjQn9zYfc_Bld0s4_z_EpudXNCwyGu2RzuajtMwCKy_h5U65_AncWQzs
link.rule.ids 315,786,790,1382,27955,27956,46327,46751
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1ta9swEBalg24w9r41W7fqwwob1KkdOXpJx6BLE5IuaWC00G9CfmOhjW2SuLD9kf3d3Vl2uozuw2DMGMcIx2efT6fnJN0jQt4KaIViVyWOUkI5vh8axwiGaVw8MgwigLbCbOTxKR-c-ycX7YsNcl3nwlh-iFWHG9aM0l9jBccO6YMb1lAcO3XckhxBYsIJFirc4Nvany6cwX40PHaGJ10P3PUe67Gm2-xO9tinlgOh_h1wFG2s0MdfVrRTCJIq9mbXgSCOb5HDSuzBSug7K_I9Surg4UOn84ugj1bMIQhZa_Hu52YByk_sqhm3wdp1lFw2c_2H5EetIDu75bJZLINm-P037sj_r8FH5EGFnOmRNfXHZCNOn5CtcTU34ClJ-9BE255NOk0xX8P2NtMsoblg-9TQr9kMfX1Z0mZ0WcyyOV0UeTkZGE5L0oppuk-Db7RcvJDmJp9eXWUzcz2dFwva4_U1i2fkvN876w6cajUJJ_QB4ziCI3SRJYEeDs8mgCz9EMJRw4xQUoRS-SriphUmiWAiVIIFUiVRwhMvNLHHnpPNNEvjbUIjpGmNEZpyCPgiXyVxzH3AklEYB1L6DTKqv7jOLWmItvTQrWrEH3SurcY1KtoetAY960rPmmlXdye6pd0G2VmzmtU94RF9JhtktzYiDb4BB3xMGmfFQntCMsk9_ucrhEC44okGeWGt7-Z5kflfSfjvpLShv3mR21-jLnr5z--4S-4OzsYjPRqefn5F7tXTBL32Dtlczov4NeDGZfCmrOQ_AenaR1s
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1ba9swFBalgzAYu1-ydaseVtigTu3I0SUdgy4Xmq5txlihb0KxLRra2CaJB9sP2e_dOZadLqN7GIwZYxth69jHR9J3JJ1PhLwW0AolvrKeUkJ5YRgZzwiGYVw8Ngw8gI7CaOSTU354Fh6dd843SFHHwjh-iFWHG5aMsr7GAp7Hdu-aNBSHTj2_5EaQGG-CiQo3-LXu1IMr2A9GfW901Augtt5hA9byW73xDvvQ9sDTvxVy1kafrf95xTqFGKkib_Y98OF4g-xXYvdWQt84kW9RUhcP77rdXwS9d2L2Qchag3cnNwvQvXWLZtyEatdBctnKDe-RH7V-3OSWy1axnLSi779RR_53Bd4ndyvcTA-coT8gG0n6kDROqpkBj0g6hAba9WvSaYrRGq6vmWaW5oLtUkMvshnW9GVKh9FlMcvmdFHk5VRguCwpK6bpLp18o-XShTQ3-fTqKpuZr9N5saADXt-zeEzOhoMvvUOvWkvCi0JAOJ7gCFxkSZ-Hg7MWcGUYgTNqmBFKikiqUMXctCNrBROREmwilY0tt0FkkoA9IZtplibPCI2RpDVBYMrB3YtDZZOEh4Ak4yiZSBk2yXH9w3XuKEO0I4duV-P9oHPtNK5R0e6gNehZV3rWTPu6N9Zt7TfJ1prRrPKEVwyZbJLt2oY01Aw43GPSJCsWOhCSSR7wP98hBIKVQDTJU2d81--LvP9KwrPj0oT-5kNu_ow66fk_z3GbND71h_p4dPrxBbldzxEMOltkczkvkpcAGpeTV2UR_wmcn0YK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Functional+inactivation+of+p73%2C+a+homolog+of+p53+tumor+suppressor+protein%2C+by+human+papillomavirus+E6+proteins&rft.jtitle=International+journal+of+cancer&rft.au=PARK%2C+Jong-Sup&rft.au=KIM%2C+Eun-Joo&rft.au=LEE%2C+Jung-Young&rft.au=SIN%2C+Hong-Sig&rft.date=2001-03-15&rft.pub=Wiley-Liss&rft.issn=0020-7136&rft.eissn=1097-0215&rft.volume=91&rft.issue=6&rft.spage=822&rft.epage=827&rft_id=info:doi/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1130%3E3.0.CO%3B2-0&rft.externalDBID=n%2Fa&rft.externalDocID=973438
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon